Usha Panchapakesan

2.1k total citations
32 papers, 1.8k citations indexed

About

Usha Panchapakesan is a scholar working on Endocrinology, Diabetes and Metabolism, Molecular Biology and Nephrology. According to data from OpenAlex, Usha Panchapakesan has authored 32 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Endocrinology, Diabetes and Metabolism, 9 papers in Molecular Biology and 8 papers in Nephrology. Recurrent topics in Usha Panchapakesan's work include Diabetes Treatment and Management (16 papers), Chronic Kidney Disease and Diabetes (8 papers) and Advanced Glycation End Products research (8 papers). Usha Panchapakesan is often cited by papers focused on Diabetes Treatment and Management (16 papers), Chronic Kidney Disease and Diabetes (8 papers) and Advanced Glycation End Products research (8 papers). Usha Panchapakesan collaborates with scholars based in Australia, Germany and United States. Usha Panchapakesan's co-authors include Carol A. Pollock, Steven J. Chadban, Harshini Mudaliar, Muralikrishna Gangadharan Komala, Jin Ma, Huiling Wu, Amanda Mather, Xinming Chen, Simon Gross and Peng Wang and has published in prestigious journals such as PLoS ONE, Scientific Reports and The FASEB Journal.

In The Last Decade

Usha Panchapakesan

32 papers receiving 1.8k citations

Peers

Countries citing papers authored by Usha Panchapakesan

Since Specialization

Citations

This map shows the geographic impact of Usha Panchapakesan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Usha Panchapakesan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Usha Panchapakesan more than expected).

Fields of papers citing papers by Usha Panchapakesan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Usha Panchapakesan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Usha Panchapakesan. The network helps show where Usha Panchapakesan may publish in the future.

Co-authorship network of co-authors of Usha Panchapakesan

This figure shows the co-authorship network connecting the top 25 collaborators of Usha Panchapakesan. A scholar is included among the top collaborators of Usha Panchapakesan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Usha Panchapakesan. Usha Panchapakesan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Organ protection beyond glycaemic control with SGLT2 inhibitors 2020 ·Nature Reviews Nephrology ·Usha Panchapakesan, Carol A. Pollock	3
2	Drug repurposing in kidney disease 2018 ·Kidney International ·Usha Panchapakesan, Carol A. Pollock	45
3	The role of toll-like receptors in diabetic kidney disease 2017 ·Current Opinion in Nephrology & Hypertension ·Usha Panchapakesan, Carol A. Pollock	22
4	Once daily administration of the SGLT2 inhibitor, empagliflozin, attenuates markers of renal fibrosis without improving albuminuria in diabetic db/db mice 2016 ·Scientific Reports ·Linda A. Gallo, Micheal Ward, Amelia K. Fotheringham, Aowen Zhuang, Danielle J. Borg, Nicole Flemming, (unknown), (unknown), (unknown), Domenica A. McCarthy, Hermann Koepsell, Volker Vallon, Carol A. Pollock, Usha Panchapakesan, Josephine M. Forbes	126
5	The DPP-4 inhibitor linagliptin and the GLP-1 receptor agonist exendin-4 improve endothelium-dependent relaxation of rat mesenteric arteries in the presence of high glucose 2015 ·Pharmacological Research ·(unknown), Usha Panchapakesan, Carol A. Pollock, Owen L. Woodman	30
6	Linagliptin Limits High Glucose Induced Conversion of Latent to Active TGFß through Interaction with CIM6PR and Limits Renal Tubulointerstitial Fibronectin 2015 ·PLoS ONE ·Muralikrishna Gangadharan Komala, Simon Gross, Amgad Zaky, Carol A. Pollock, Usha Panchapakesan	23
7	The Role of Dipeptidyl Peptidase – 4 Inhibitors in Diabetic Kidney Disease 2015 ·Frontiers in Immunology ·Usha Panchapakesan, Carol A. Pollock	35
8	The Role of TLR2 and 4-Mediated Inflammatory Pathways in Endothelial Cells Exposed to High Glucose 2014 ·PLoS ONE ·Harshini Mudaliar, Carol A. Pollock, Jin Ma, Huiling Wu, Steven J. Chadban, Usha Panchapakesan	92
9	Inhibition of Kidney Proximal Tubular Glucose Reabsorption Does Not Prevent against Diabetic Nephropathy in Type 1 Diabetic eNOS Knockout Mice 2014 ·PLoS ONE ·Muralikrishna Gangadharan Komala, Simon Gross, Harshini Mudaliar, Chunling Huang, (unknown), Amanda Mather, Sylvie Shen, Carol A. Pollock, Usha Panchapakesan	62
10	TLR4 Activation Promotes Podocyte Injury and Interstitial Fibrosis in Diabetic Nephropathy 2014 ·PLoS ONE ·Jin Ma, Steven J. Chadban, Cathy Zhao, Xiaochen Chen, Tony Kwan, Usha Panchapakesan, Carol A. Pollock, Huiling Wu	132
11	DPP4 Inhibition in Human Kidney Proximal Tubular Cells - Renoprotection in Diabetic Nephropathy? 2013 ·Journal of Diabetes & Metabolism ·Usha Panchapakesan	12
12	Sodium glucose cotransporter 2 and the diabetic kidney 2012 ·Current Opinion in Nephrology & Hypertension ·Muralikrishna Gangadharan Komala, Usha Panchapakesan, Carol A. Pollock, Amanda Mather	43
13	HMGB1 Contributes to Kidney Ischemia Reperfusion Injury 2010 ·Journal of the American Society of Nephrology ·Huiling Wu, Jin Ma, Peng Wang, Theresa M. Corpuz, Usha Panchapakesan, Kate Wyburn, Steven J. Chadban	294
14	Renal epidermal growth factor receptor: Its role in sodium and water homeostasis in diabetic nephropathy 2010 ·Clinical and Experimental Pharmacology and Physiology ·Usha Panchapakesan, Carol A. Pollock, Sonia Saad	23
15	Review article: Importance of the kidney proximal tubular cells in thiazolidinedione‐mediated sodium and water uptake 2009 ·Nephrology ·Usha Panchapakesan, Carol A. Pollock, Sonia Saad	19
16	Nanomedicines in the treatment of anemia in renal disease: focus on CERA (Continuous Erythropoietin Receptor Activator) 2007 ·International Journal of Nanomedicine ·Usha Panchapakesan, (unknown), Carol A. Pollock	10
17	PPARγ agonists exert antifibrotic effects in renal tubular cells exposed to high glucose 2005 ·American Journal of Physiology-Renal Physiology ·Usha Panchapakesan, (unknown), Carol A. Pollock, Xinming Chen	82
18	Drug Insight: thiazolidinediones and diabetic nephropathy—relevance to renoprotection 2005 ·Nature Clinical Practice Nephrology ·Usha Panchapakesan, Xinming Chen, Carol A. Pollock	39
19	The effect of high glucose and PPAR-γ agonists on PPAR-γ expression and function in HK-2 cells 2004 ·American Journal of Physiology-Renal Physiology ·Usha Panchapakesan, Carol A. Pollock, Xinming Chen	68
20	Recovery of pure red‐cell aplasia secondary to antierythropoietin antibodies after cessation of recombinant human erythropoietin 2003 ·Internal Medicine Journal ·Usha Panchapakesan, Steve Austin, (unknown), J. A. Lawrence, Elliott Savdie	4

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact